Introduction
Notch family genes encode cell surface receptors found in a variety of organisms including Drosophila, Xenopus and higher vertebrates. The Notch signaling pathway is involved in a broad range of cell fate decisions and its function in Drosophila morphogenesis has been well documented (Artavanis-Tsakonas et al., 1995 . The knowledge accumulated in this ®eld has provided the framework to explore the function of Notch signaling in mammalian hematopoiesis (Osborne and Miele, 1999) . Several in vivo studies have shown that Notch aects cell fate decisions in lymphoid development. Transgenic mice models in which expression of the Notch1 intracellular domain (Notch1IC, a constitutively active form of Notch1) was under the control of the lck proximal promoter suggested that Notch may have a role in both CD4/CD8 and ab/gd T cell lineage determination (Robey et al., 1996; Washburn et al., 1997) . Using a similar transgenic construct, Deftos et al. (2000) showed that Notch1 activation induced the development of thymocytes to both CD4 and CD8 single positive (SP) lineages with a bias toward CD8 development. By transplanting bone marrow retrovirally transduced with Notch1IC, Pear's group demonstrated the development of T cell leukemia/lymphomas in transplanted mice, and suggested that Notch1 signaling favors T cell fate in the T versus B lymphoid cell commitment (Pear et al., 1996; Pui et al., 1999) . This was con®rmed by loss of function studies in which ablation of Notch1 in the thymus resulted in the maturation of thymic B cells at the expense of T cells . These gain and loss of function studies in vivo did not reveal any eect of Notch1 on myeloid development. While, several in vitro studies based on the myeloid cell line 32D have shown contradictory eects of Notch1 activation on myeloid dierentiation (Milner et al., 1996; Schroeder and Just, 2000) .
The activation of Notch by ligand stimulation induces its proteolytic cleavage that leads to the release of the intracellular domain of Notch (NotchIC) which translocates into the nucleus where it interacts with the transcriptional regulator CBF1. Several Notch target genes have been identi®ed but one of the most important targets of Notch signaling is a family of basic helix ± loop ± helix (HLH) transcription factors known as HES (Hairy-Enhancer of Split). Like Notch, HLH factors are highly conserved proteins that are key players in the commitment of cell fate during the development of multiple tissues. The vertebrate HLH factors are subdivided into seven groups (class I-VII) based on tissue distribution, dimerization capabilities and DNA binding site speci®cities (Massari and Murre, 2000) . In response to dierentiation signals HLH factors form hetero-or homodimers consisting of class I (i.e. E2A) and class II (i.e. Math1, MyoD, NeuroD) factors on a speci®c DNA motif, the E box. This transcriptional response can be regulated by the formation of non-functional heterodimers between the class VI factors Hes (Hes1,2,3,5) and either class I or class II factors and/or by the binding of Hes to a negative regulatory motif, the N box. Following Notch activation, the NotchIC/CBF1 complex binds to the Hes promoter and activates its transcription (Jarriault et al., 1998; Lu and Lux, 1996) . Ohtsuka et al. (1999) showed for example that Hes1 and Hes5 are targets of Notch1 signaling in neural development. Hes1 is particularly interesting in the context of hematopoiesis because it is expressed in the immune system and it is necessary for thymic T cell development (Tomita et al., 1999) . In addition to the CBF1-dependent Hes1/Hes5 pathway, a CBF1-dependent NF-kB2 pathway (Oswald et al., 1998) and CBF1-independent pathways (Ordentlich et al., 1998) have been reported. The CBF1-independent pathways are best highlighted by Deltexmediated events. In this pathway, a zinc ®nger cytoplasmic protein Deltex is reported to bind to Notch IC and mediate signaling that blocks Ras-and JNK-mediated activation of E2A (E47). Recently Notch was also shown to activate the transcription factor LEF-1 which regulates the TCR-a enhancer (Ross and Kadesch, 2001) . Thus the activation of Notch could trigger both CBF1-dependent and -independent pathways that induce various cellular responses. However, the role of Hes genes in mediating Notch1 signaling in mammalian hematopoiesis has not been extensively studied. To address this issue, we transplanted irradiated mice with hematopoietic progenitors expressing Hes genes or a constitutively active form of Notch1 and compared their hematopoietic reconstitution.
Results
The overexpression of Hes1, Hes5 or of a constitutively active form of Notch1 suppresses the development of the B cell lineage in vivo
To study the eects of Hes overexpression on hematopoiesis we used a mouse bone marrow (BM) transduction/transplantation model. BM from BA.1 (Ly5.2) donor mice was enriched in early hematopoietic precursors by depletion of the lineage positive cells resulting in a Lin neg/low population consisting of approximately 2% of the whole BM. This Lin neg/low population was retrovirally transduced with the Hes1, Hes2, Hes3 or Hes5 gene using the Mie vector (Du et al., 1999) that generates a bicistronic transcript encoding an internal ribosomal entry site (IRES) followed by the enhanced green¯uorescent protein (eGFP). Lethally irradiated BS/BA (Ly5.1) recipient mice were injected with the transduced Lin neg/low cells together with syngenic (Ly5.1) BM to ensure shortterm radioprotection. Eight weeks after transplantation, the mice were terminated and the BM, spleen, thymus and peripheral blood (PB) from the transplanted mice were harvested for examination. The fraction of transduced eGFP+ populations found in the BM and their content in B, T and myeloid cells are shown in Figure 1a . Similar results were found in the spleen and PB (data not shown). We found that the B cell lineage was considerably suppressed in the Hes5-and Hes1-, albeit to a lesser extent, transduced cells (Figure 1a,b) . Furthermore, a dosage eect of Hes1 and Hes5 on B cell suppression could be seen by restricting the eGFP+ population to the cells expressing high levels of eGFP (Figure 1b) . In contrast, no notable perturbation of hematopoietic maturation was noted in the Hes2 and Hes3 transplanted mice.
The reported inhibitory activity of Notch1 on B cell development (Pui et al., 1999) prompted us to repeat side by side transduction/transplantation experiments with Hes1, Hes5 or the constitutively active form of Notch1, Notch1IC. Since Notch1IC transplanted mice rapidly develop T cell lymphoma/leukemias, the mice were analysed 3 or 4 weeks after transplantation. As expected, B cell development was completely blocked among the Notch1IC-transduced cells while it was only partially suppressed in Hes1 or Hes5 expressing cells at 3 weeks post transplantation (Figure 1b) . In contrast to Notch1IC transplanted mice, no marked eect of Hes1 or Hes5 on T cell development was observed and none of the Hes transplanted mice demonstrated signs of illness for as long as 1 year after transplantation.
To characterize at which maturational stage of the B lineage the Hes1-and Hes5-overexpressing cells were altered, we measured among the fraction of eGFP+ cells expressing CD19, a marker found throughout Blymphocyte development, the expression of the surface markers CD43, CD24, BP-1 and IgM in order to characterize the stages of B lymphoid dierentiation (Hardy et al., 1991) . We found that the distribution of these markers among the CD19+ B cell population was not signi®cantly altered in Hes1-and Hes5-mice compared to that seen in Mie controls (Figure 1c ). This shows that the decrease in B cell number was not accompanied by the accumulation of an immature Blymphocyte sub-population, suggesting that the defect in B cell maturation occurred at the level of a very early precursor.
Hes1 and Hes5 are upregulated in Notch1IC transplanted mice
Notch1 signaling has been reported to activate the promoters of Hes1 and Hes5, but not that of Hes2 or Hes3 in vitro (Nishimura et al., 1998) . In line with this, only Hes1 and Hes5 mice displayed an impairment of cells resembling the one seen in Notch1IC mice. To explore whether the eect of Notch1 on B cells could be mediated by the upregulation of Hes1 and Hes5, we examined the expression of their mRNAs in the BM Effects of Hes on hematopoiesis S Kawamata et al and spleen of Notch1IC transplanted mice. We veri®ed by Northern blotting that the retrovirally-transduced genes were expressed in the BM of the transplanted mice (the corresponding bands are indicated by arrows on Figure 2a ). We also found that Hes1 and Hes5 mRNA were upregulated in the BM of Notch1IC transplanted mice. However, their expression was not readily detectable in the spleen and only after polyA enrichment, could the mRNA of Hes1, not that of Hes5, be detected by Northern blotting (Figure 2b ). These results suggest that the induction of Hes1 and Hes5 genes by Notch1 in hematopoietic tissue may vary with the nature of the predominant lineage and/or the degree of maturation of the hematopoietic cells.
Hes1, Hes5 and Notch1 antagonize the transcriptional activity of E2A
The class I HLH factor E2A (E47,E12) plays a key role in triggering the transcription of genes required for B cell maturation through the formation of E2A homodimers on the E box motif (Bain et al., 1994) . It seems likely that overexpression of the class VI bHLH factors Hes could inhibit B cell development by interfering with E2A. Previous studies have indeed demonstrated that Notch1IC as well as some Hes proteins interfered with the transcriptional activity of E2A (Akazawa et al., 1992; Hirata et al., 2000; Ishibashi et al., 1993; Pui et al., 1999; Takebayashi et al., 1994) . To determine if the B cell inhibition seen in our transplanted mice correlated with the ability of the transgenes to inhibit the transcriptional activation of E2A, we compared their activity using an E box reporter assay. As shown in Figure 3 , Hes1, Hes5 or Notch1IC inhibited the transactivating properties of the E2A product, E47, while Hes2 or Hes3 did not. These results correlate with the phenotype observed with these genes on B cell maturation in vivo (see Figure 1a ,b). Altogether, our data suggest that the perturbation of B cell development among the Notch1IC-transduced cells could be mediated in part by the induction of Hes1/Hes5 and the ability of these proteins to repress the transcriptional activity of E2A.
The maturation potential of myeloid progenitors is altered in Hes1, Hes5 and Notch1IC mice
In the Notch1IC-transplanted mice, the eGFP+ BM compartment was occupied by proliferating CD4/CD8 double positive (DP) T cells resulting in a considerable suppression of the myeloid compartment ( Figure 1b) . In contrast, the myeloid population of Hes1 or Hes5 reconstituted mice appeared to be unaected (Figures 1a, b and 4a) . To further explore the eects of Hes1, Hes5 or Notch1 on myeloid development, we seeded BM cells from the transplanted mice in colony forming assays. After 2 weeks of culture in the presence of interleukin (IL)-3, IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF), the cells were harvested from the methylcellulose cultures and analysed by¯ow cytometry for eGFP expression and myeloid maturation. Myeloid clonogenic cells from Hes5 mice had a higher proliferative potential generating bigger colonies that contained approximately twofold more cells than progenitors from Mie or Hes1 mice (see Table 1 , ®rst round of plating). In contrast, Notch1IC BM cells had a very low seeding eciency likely because of the predominance of DP T cells in these mice. Interestingly, the Hes1-, Hes5-and Notch1IC-transduced cells that grew in the myeloid clonogenic assay remained very immature compared to the Mie controls. Indeed, more than 80% of the eGFP+ BM cells from Hes1, Hes5 or Notch1IC mice remained negative for Gr-1 and Mac-1 whereas these undierentiated cells represented less than 20% of cultures initiated with BM from Mie mice (Figure 4b ). Moreover the Hes1-, Hes5-and Notch1IC-transduced cells harvested from the clonogenic assay retained their colony forming capability when replated in methylcellulose (Table 1) , while Mie control transduced cells did not. These results indicate that although the myeloid compartments of Hes1 or Hes5 mice appeared normal, their ability to respond to growth factors ex vivo was altered. The myeloid clonogenic assay initiated with BM from Hes2 or Hes3 mice generated essentially the same result as the control (data not shown).
The effects of Hes1, Hes5 or Notch1IC on the development of thymocytes Both Hes1 and Notch1 have been implicated in the maturation process of thymocytes (Kim and Siu, 1998; Robey et al., 1996; Tomita et al., 1999) . However, analysis of CD4 and CD8 expression in the thymus of Hes1 or Hes5 transplanted mice at 3, 8 (Figure 5a,b) , 10 or 20 weeks after transplantation did not reveal any gross alteration in T cell maturation in our transplantation model. Even the subsets of Hes1-or Hes5-transduced cells expressing high levels of eGFP had a normal distribution of CD4 and CD8 expression (data not shown). We also found that despite the neoplastic proliferation of DP cells in their BM, the transduced thymocytes of the Notch1IC transplanted mice displayed a relatively normal distribution of CD4 and CD8 expression. This could be seen at 3 weeks post transplantation (Figure 5b ,c) regardless of the initial transduction eciency or of the proportion of eGFP+ cells present in thymus. We also did not ®nd that restricting the analysis to the cells expressing the highest level of eGFP had an in¯uence on their ability to dierentiate into CD4 and CD8 SP (data not shown). Even in the terminally ill mice the Notch1IC-transduced cells had a normal CD4/CD8 distribution. We could not see any marked eects of Notch1IC on the cell fate decision between TCRab versus TCRgd either (data not shown). Interestingly, when the Notch1IC mice became terminally ill from the leukemia/lymphomas, the DP cells among the eGFPpopulation of the thymus became very scarce ( Figure  5c : Notch1IC (2)). 
Discussion
In this study we describe hematopoietic alterations induced by Notch1 activation that can also be generated by overexpressing certain Hes genes. Although to a lesser degree than Notch1IC, Hes1 or Hes 5 overexpression in progenitor cells abrogated the generation of B lymphocytes in vivo. Hes1 and Hes5 were equivalent to Notch1IC in their ability to inhibit the myeloid maturation of progenitors in response to growth factors ex vivo. This is the ®rst study to show that Notch1 activation alters the ability of progenitors to mature along the myeloid lineage in vivo. It is in line with previous work showing that Notch ligands induced the self-renewal of hematopoietic progenitors in culture (Carlesso et al., 1999; Varnum-Finney et al., 1998) . Both Hes 1 and Hes 5 have been shown to be transcriptional targets of Notch signaling in neural cells (Ohtsuka et al., 1999) and we veri®ed here that this is also the case in bone marrow. Taken together these ®ndings suggest that Hes1 and Hes5 can mediate some of the biological activities of Notch1 activation in B lymphoid and myeloid cells. The partial block in B cell maturation seen with Hes1 and Hes5 overexpression compared to that seen in Notch1IC-transduced cells could have several explanations. We found that Hes1 and Hes5 blocked B cells in a dose dependent fashion (Figure 1b ), it is therefore theoretically possible that the expression of these genes transcribed from the proviral inserts is lower in B cell precursors than it is from the endogenous genes in response to Notch1 activation. This seems very unlikely judging from the much higher level of Hes1 and Hes5 transcripts seen in the BM of Hes mice compared to that seen in Notch1IC mice (Figure 2) . It is also possible that both Hes1 and Hes5 have to be expressed simultaneously to see a complete block in B cell maturation. Alternatively, additional Hes-independent Notch1 pathways such as the one involving the Notch interacting protein Deltex (Ordentlich et al., 1998) could mediate further suppression of B cell development in Notch1IC-transduced cells. The suppression of B cell development by Notch1IC could involve the inhibitory eect of Hes1 and Hes5 on the transcriptional activity of the E2A gene product. It is tempting to speculate that the block in myeloid maturation potential seen in the BM progenitors of Notch1IC-transplanted mice might also result from a possible interaction of Hes proteins with other bHLH proteins such as TAL-1/SCL that control myeloid maturation (Condorelli et al., 1997) . Interestingly Hes1 has also been shown to interact with the AML-1 gene product, which is another critical regulator of hematopoietic cell development (McLarren et al., 2000) . It is also possible that (a) Hes- P labeled Hes1 (left), Hes5 (middle), Notch1IC (right) or G3PDH (bottom). The arrows point to the band that corresponds to the size of the unspliced transcript generated from the provirus. (b) Expression of endogenous Hes genes in the spleen of Notch1IC mice. 500 ng of spleen polyA RNA were hybridized with Hes1 (left), Hes5 (right) and G3PDH (bottom) probes. The blot of spleen RNA hybridized with the Hes5 probe was analysed after long (1 week) exposure (right). 38% of cells in the spleen of the Notch1IC mouse were eGFP+. Molecular size makers are shown in kb independent pathway(s) could contribute to the alteration of myeloid maturation. Indeed we observed that spleen progenitors from Notch1IC mice did not mature properly in a myeloid colony forming assay, while spleen progenitors from Hes1 and Hes5 mice dierentiated normally (data not shown).
The most striking consequence of Notch1IC overexpression in vivo is the generation of tumors restricted to the T cell lineage (Pear et al., 1996) . The critical downstream events that contribute to transformation of T lymphocytes are unknown but Hes1 appeared as a potentially important target since like Notch1 it is involved with commitment to the T cell fate (Tomita et al., 1999) . Furthermore, structure function studies showed that the minimal transforming region of Notch1IC was a strong activator of transcription which could in particular activate the Hes1 promoter (Aster et al., 2000) . We show here that the T cell proliferation seen in the BM of Notch1IC-transplanted mice is not observed in Hes-transplanted mice that remained healthy throughout this study. Although we found a dose dependent suppression of B cell development by Hes1 and Hes5 genes, we could not observe any eect of Hes genes on T cell development in BM even among the eGFP bright population. While the suppression of B cell development and ectopic development of T cell in BM are coupled in Notch1IC mice, they appear to be independent in Hes1 and Hes5 mice. This suggests that Hes genes do not mediate the Notch1-induced alterations that lead to the development of T cell leukemia/lymphomas and that other Notch1 signaling pathway(s) than the suppression of E2A are involved.
Studies of Hes1-de®cient mice have shown that like Notch1, Hes1 was essential for proper T cell development (Tomita et al., 1999) . Here we found that overexpression of Hes1 does not perturb T cell maturation in the thymus. This is in line with a study indicating that fetal thymocytes overexpressing Hes1 matured normally in fetal thymus organ culture (Kaneta et al., 2000) . The studies on the role of Notch1 in the CD4 versus CD8 cell fate choices have generated contradictory results. In lck-Notch1IC transgenic mice, Notch1 was shown to bias the development of thymocytes towards the CD8 lineage at the expense of the CD4 lineage (Robey et al., 1996) . In another study using a similar experimental approach, Notch1 was shown to also favor the maturation of CD8 SP thymocytes while also stimulating the development of CD4 SP (Deftos et al., 2000) . Other studies suggest that Notch1 has no in¯uence on CD4/ CD8 cell fate choices. Tissue-speci®c inactivation of Notch1 in immature thymocytes demonstrated that Notch1 signaling did not play a role in CD4/CD8 lineage commitment, maturation or survival during thymus development (Wolfer et al., 2001) . Our ®nding that the distribution of CD4 and CD8 expressing cells was not altered in Notch1IC mice compared to Mie control corroborates the results of this loss of function study. It is also in line with the ®nding that Notch1IC-transduced hematopoietic stem cells injected in the thymus of recipient mice matured normally (Koch et al., 2001) . Our data also suggest that one of the eects of Notch1 signaling may be to suppress apoptosis of the T cell lineage. This was apparent in the thymus of transplanted mice that were sacri®ced at the very terminal phase of T cell leukemia/lymphomas. At this advanced stage of the disease, DP thymocytes were present among the Notch1 IC-transduced cells, while no DP cells were present among the non-transduced compartment (Figure 5c , Notch1 IC (2)). This depletion of DP thymocytes evokes a pro®le of glucocorticoidsmediated apoptosis (Scollay et al., 1984; Screpanti et al., 1989) that could result from the systemic release of corticosteroid in the terminally sick mice. The presence of numerous DP cells among the Notch1IC expressing cells suggests that these cells have acquired the ability to survive as a result of the anti-apoptotic eect of Notch1. A protective eect of Notch signaling against corticoid-induced apoptosis has indeed been reported in vitro (Deftos et al., 1998) . Our animal model provides con®rmation that this anti-apoptotic activity of Notch1 is likely to take place in vivo as well.
Our results indicate that like Notch1, Hes genes can modulate the development of hematopoietic cells at multiple levels in vivo. The level of their expression can in¯uence not only the maturation of T lymphocytes as was shown in Hes1-null mice, but it is also critical to the appropriate distribution and function of myeloid and B lymphoid cells. Thymocytes were collected from Mie and Notch1IC mice 3 weeks after transplantation and the expression of CD4 and CD8 was analysed in the eGFP+ and eGFP7 populations. Notch1IC (1) represents a Notch1IC transplanted mice that was relatively healthy at the time of analysis. Notch1IC (2) represents a transplanted mouse that was sacri®ced at a very advanced stage of the disease. The FACS pro®les of the thymus for the Mie control, Notch1IC (1) or (2) are representative of ten, seven or three mice respectively
Materials and methods

Constructs
Based on published sequence, cDNA fragments of human Hes1, mouse Hes2, mouse Hes3 covering the entire coding region were cloned by PCR from human placenta and mouse 11-day embryo libraries (Clontech, Palo Alto, CA, USA). The identity of the PCR products were con®rmed by sequencing. Human Hes1, mouse Hes2, mouse Hes3, Rat Hes5 gene (a gift of Dr Kageyama) and mouse Notch1IC cDNA encoding the totality of the intracellular domain (from codon 1474 to 2531, a gift of Dr Cleary) were cloned into the retroviral vectors MSCV (Hawley et al., 1994) and Mie (MSCV-IRES-eGFP) (Du et al., 1999) .
Retroviral transduction of bone marrow cells and reconstitution of mice
C57BL/Ka-Ly5.2, Thy1.1 mice (known as B.A1), C57BL/KaLy5.1, Thy1.1 mice (known as B.S/B.A) were bred and maintained in the animal facility at SyStemix. Four-week-old B.A1 (Ly5.2) mice were injected i.v. with 150 mg/kg 5-FU in PBS 5 days prior to sacri®ce. Bone Marrow (BM) cells from 4-week-old B.A1 mice were collected, followed by red blood cell lysis. Primitive hematopoietic precursors were enriched by depleting lineage positive cells using a panel of antibodies directed against CD3, CD5, CD8a, CD11b (Mac-1), Gr-1 and B220 (Pharmingen, San Diego, CA, USA) followed by a step of negative selection using Dynabeads M-450 (Dynal S.A, Oslo, Norway). The retroviral transduction of the resulting Lin neg/low cells was performed as described previously (Slany et al., 1998) . The transduction eciency was determined by¯ow cytometric measurement of eGFP expression among the Lin neg/low population on the day following the second round of spinoculation. Lethally irradiated (1050 Rad X 1 total g irradiation) B.S/B.A. (Ly5.1) recipient mice were transplanted with 15 000 to 20 000 Lin neg/low transduced B.A1 cells together with 100 000 syngenic whole BM (Ly5.1) cells for short-term irradiation protection.
Flow cytometric analysis and methylcellulose assay
The cells harvested from BM, PB, spleen and thymus or following culture in vitro were stained with antibodies directed against Ly5.1, CD4, CD8a, CD3, CD11b (Mac-1), CD19, CD24, CD43, BP-1, IgM or Gr-1 (Pharmingen). Stained cells were resuspended with propidium iodide (5 mg/ ml) to exclude nonviable cells and analysed on a FACSCalibur (Becton Dickinson, San Jose, CA, USA) or a Vantage (Becton Dickinson). Light scatter gating was set to include all nucleated cells.
Twenty thousand BM cells from Hes1, Hes5 or Notch1IC transplanted mice were seeded in 1.1 ml of Methocult M3320 methylcellulose media (Stem Cell Technologies Inc., Vancouver, Canada) supplemented with murine IL-3, IL-6, GM-CSF (all 10 ng/ml, R&D system, Minneapolis, MN, USA) and SCF (100 ng/ml, supplied by Novartis). After 2 weeks of culture, colonies were scored and cells pooled from the culture dish were harvested, counted and analysed bȳ ow cytometry for eGFP expression and myeloid maturation markers by staining the cells with antibodies directed against CD11b (Mac-1) and Gr-1 (Pharmingen). For secondary colony assays 12 000 harvested cells were replated in methyl celluloses dishes with the same combination of cytokines.
BM, splenic and thymic cells were stained with antibodies directed against CD4, CD8a, CD19, CD24, CD43, BP-1, CD11b (Mac-1), or Gr-1 (Pharmingen) and analysed by¯ow cytometry to determine the degree of maturation along the T, B or myeloid lineages.
Northern blotting
Total RNA was isolated from BM and spleen of control Mie, Hes1, Hes5 or Notch1IC transplanted mice with Stat-60 RNA extraction reagent (Tel-Test`B', Inc., Friendswood, TX, USA). The mRNA was puri®ed from total RNA obtained from spleen samples with a mRNA puri®cation kit (Amersham Pharmacia Biotech Inc., Piscataway, NJ, USA). A total of 15 mg of total RNA or 500 ng of mRNA was fractionated by electrophoresis through 1.2% agarose/ formaldehyde denaturing gel and transferred to a nylon membrane (Boehringer Mannheim, Mannheim, Germany). The membranes were hybridized with 32P labeled probes.
E-box reporter gene assay and ELISA
Eight hundred thousand HEK 239T were seeded in 2 ml of DMEM media (JRH Bioscience, Lenexa, KS, USA) with 10% FCS (Gemini Bio Products, Inc., Calabasas, CA, USA). The following day, 1.0 mg of MSCV, MSVC-Hes1, -Hes2, -Hes3, -Hes5 or -Notch1IC construct was transfected together with 1.0 mg of E-box luciferase reporter gene, pE7bA-Luc. (Akazawa et al., 1995) , 1.0 mg of E47 construct, pSV2-CMVhE47 (Akazawa et al., 1995) or pSV2-CMV and 0.5 mg of pCMV b-gal (Kawamata et al., 1998) . Transfected cells were harvested and lyzed in accordance with the manufacturer's protocol (Promega, Madison, WI, USA) at day 2. Twenty ml of cell extract from each sample were used to measure the luciferase activity in accordance with manufacturer's protocol (Promega) with a microtiter plate luminometer (DYNEX, Chantilly, VA, USA). Forty ml of cell extract were used to measure b-galactosidase activity as an internal control. The luminescence values were normalized by the individual bgalactosidase activity.
